To test the combination of oxaliplatin chemotherapy in combination with taxotere chemotherapy in patients with advanced bladder cancer who have failed one prior chemotherapy.
To combine oxaliplatin and taxotere in patients who have had prior cisplatin therapy in bladder cancer.